- Home
- INDP vs BREA Comparison
INDP vs BREA Comparison
Compare INDP & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- BREA
- Stock Information
- Founded
- INDP 2000
- BREA 2022
- Country
- INDP United States
- BREA Ireland
- Employees
- INDP N/A
- BREA N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- INDP Health Care
- BREA Consumer Discretionary
- Exchange
- INDP Nasdaq
- BREA Nasdaq
- Market Cap
- INDP 6.0M
- BREA 14.8M
- IPO Year
- INDP N/A
- BREA 2023
- Fundamental
- Price
- INDP $2.28
- BREA $6.85
- Analyst Decision
- INDP Strong Buy
- BREA
- Analyst Count
- INDP 2
- BREA 0
- Target Price
- INDP $238.00
- BREA N/A
- AVG Volume (30 Days)
- INDP 193.3K
- BREA 8.2K
- Earning Date
- INDP 11-11-2025
- BREA 01-01-0001
- Dividend Yield
- INDP N/A
- BREA N/A
- EPS Growth
- INDP N/A
- BREA N/A
- EPS
- INDP N/A
- BREA N/A
- Revenue
- INDP N/A
- BREA $2,988,009.00
- Revenue This Year
- INDP N/A
- BREA N/A
- Revenue Next Year
- INDP N/A
- BREA N/A
- P/E Ratio
- INDP N/A
- BREA N/A
- Revenue Growth
- INDP N/A
- BREA 151.51
- 52 Week Low
- INDP $2.26
- BREA $5.00
- 52 Week High
- INDP $58.24
- BREA $19.50
- Technical
- Relative Strength Index (RSI)
- INDP 20.16
- BREA 55.61
- Support Level
- INDP $2.34
- BREA $5.87
- Resistance Level
- INDP $2.86
- BREA $6.42
- Average True Range (ATR)
- INDP 0.69
- BREA 0.38
- MACD
- INDP -0.24
- BREA 0.11
- Stochastic Oscillator
- INDP 1.22
- BREA 55.34
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.